Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (21-30 of 321) with videos related to

Pageof 33
Sort By:
Targeted Oncology|September 8, 2010
Vascular endothelial growth factor inhibitors in malignant gliomasPriscilla K Brastianos, Tracy T Batchelor
Clinical Lymphoma|November 15, 2001
Advances in the therapy of primary central nervous system lymphomaS R Plotkin, T T Batchelor
Physical Review. E|July 18, 2018
Anomalous bulk behavior in the free parafermion Z(N) spin chainFrancisco C Alcaraz, Murray T Batchelor
Hematology/Oncology Clinics of North America|November 23, 2006
Supportive care of brain tumor patientsTracy T Batchelor, Thomas N Byrne
Onkologie|March 8, 2007
Reversible posterior leukoencephalopathy syndromeAndrew D Norden, Tracy T Batchelor
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Antiangiogenic therapy for glioblastomaElizabeth R Gerstner, Tracy T Batchelor
Current Treatment Options in Oncology|October 24, 2002
Primary nervous system lymphomaScott R Plotkin, Tracy T Batchelor
The Lancet. Oncology|March 22, 2002
Primary nervous-system lymphomaS R Plotkin, T T Batchelor
Chinese Clinical Oncology|July 15, 2017
Isocitrate dehydrogenase mutation as a therapeutic target in gliomasCatherine H Han, Tracy T Batchelor
The Journal of Communication|September 1, 1972
Some message variables and the MUM effectA Tesser, S Rosen, T Batchelor
Pageof 33

Showing results (21-30 of 321) with videos related to

Sort By:
Pageof 33
Targeted Oncology|September 8, 2010
Vascular endothelial growth factor inhibitors in malignant gliomasPriscilla K Brastianos, Tracy T Batchelor
Clinical Lymphoma|November 15, 2001
Advances in the therapy of primary central nervous system lymphomaS R Plotkin, T T Batchelor
Physical Review. E|July 18, 2018
Anomalous bulk behavior in the free parafermion Z(N) spin chainFrancisco C Alcaraz, Murray T Batchelor
Hematology/Oncology Clinics of North America|November 23, 2006
Supportive care of brain tumor patientsTracy T Batchelor, Thomas N Byrne
Onkologie|March 8, 2007
Reversible posterior leukoencephalopathy syndromeAndrew D Norden, Tracy T Batchelor
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Antiangiogenic therapy for glioblastomaElizabeth R Gerstner, Tracy T Batchelor
Current Treatment Options in Oncology|October 24, 2002
Primary nervous system lymphomaScott R Plotkin, Tracy T Batchelor
The Lancet. Oncology|March 22, 2002
Primary nervous-system lymphomaS R Plotkin, T T Batchelor
Chinese Clinical Oncology|July 15, 2017
Isocitrate dehydrogenase mutation as a therapeutic target in gliomasCatherine H Han, Tracy T Batchelor
The Journal of Communication|September 1, 1972
Some message variables and the MUM effectA Tesser, S Rosen, T Batchelor
Pageof 33